8-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________
FORM 8-K
CURRENT
REPORT
PURSUANT
TO SECTION 13 OR 15(d) OF THE
SECURITIES
EXCHANGE ACT OF 1934
Date of
Report (Date of earliest event reported): April 18, 2017
CHROMADEX CORPORATION
(Exact
name of registrant as specified in its charter)
|
Delaware
|
001-37752
|
26-2940963
|
|
(State
or other jurisdiction of incorporation)
|
(Commission
File Number)
|
(IRS
Employer Identification No.)
|
10005 Muirlands Boulevard, Suite G, Irvine, California,
92618
(Address
of principal executive offices, including zip code)
(949) 419-0288
(Registrant's
telephone number, including area code)
Check
the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant
under any of the following provisions:
[
]Written communications pursuant to Rule 425 under the Securities
Act (17 CFR 230.425)
[
]Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)
[
]Pre-commencement communications pursuant to Rule 14d-2(b) under
the Exchange Act (17 CFR 240.14d-2(b))
[
]Pre-commencement communications pursuant to Rule 13e-4(c) under
the Exchange Act (17 CFR 240.13e-4(c))
Indicate by check mark whether the
registrant is an emerging growth company as defined in
Rule 405 of the Securities Act of 1933 (§230.405 of this
chapter) or Rule 12b-2 of the Securities Exchange Act of 1934
(§240.12b-2 of this chapter).
Emerging growth
company ☐
If an
emerging growth company, indicate by check mark if the registrant
has elected not to use the extended transition period for complying
with any new or revised financial accounting standards provided
pursuant to Section 13(a) of the Exchange
Act. ☐
Item 8.01. Other Events.
On
April 18, 2017, ChromaDex Corporation (the “Company”)
included certain previously nonpublic information about the Company
in its corporate presentation, which the Company is making
available on its website.
A copy
of the corporate presentation is attached hereto as Exhibit 99.1.
The foregoing is incorporated herein by reference and constitutes
part of this report.
|
Item 9.01.
|
Financial Statements and Exhibits.
|
(d)
Exhibits.
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
99.1
|
|
Investor
Presentation of ChromaDex Corporation
|
|
|
|
|
|
|
|
|
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the
Registrant has duly caused this report to be signed on its behalf
by the undersigned thereunto duly authorized.
Dated:
April 18, 2017
|
|
CHROMADEX CORPORATION
By:
/s/ Thomas C.
Varvaro
Name: Thomas C. Varvaro
Title: Chief Financial Officer
|
INDEX TO EXHIBITS
|
Exhibit
No.
|
|
Description
|
|
|
|
|
|
99.1
|
|
Investor
Presentation of ChromaDex Corporation
|
|
|
|
|
|
|
|
|